Veru: “Veru is in [Phase 3] for a very important breast cancer indication. They just got fast-track designation by the FDA this morning. It’s at $5. It made no sense that the stock didn...
Veru: “Veru is in [Phase 3] for a very important breast cancer indication. They just got fast-track designation by the FDA this morning. It’s at $5. It made no sense that the stock didn...